News
Immunologists at UNIGE have revealed a previously unknown anti-tumor role of CD4 T lymphocytes, marking a breakthrough that ...
When it comes to a clinical study to evaluate the therapeutic effect of Shivagutika treatment in patients with HIV, it was ...
Incomplete immune recovery despite sustained virologic suppression in patients with HIV was associated with increased risk for incident cancer.
The Australian researchers developed a novel mRNA-based technology capable of reaching the white blood cells where HIV lies ...
Discover how understanding your viral load and CD4 count puts you in control of HIV treatment and transforms confusing ...
Lenacapavir, the injectable drug developed by a US-based company, Gilead Sciences, was trialled (tested) in Uganda and South ...
HIV remains incurable but manageable. Johns Hopkins found a way to silence it long-term using a molecule from the virus ...
A new nanozyme-powered TB test improves detection in people with HIV, offering rapid, electricity-free diagnosis via a beetle-inspired chip.
Whether antiretroviral therapy (ART) is always completely suppressive, or HIV might continue to replicate at low levels despite ART in some people with HIV (PWH), is still debated. Here, we ...
Gene therapy may be a crucial tool to put HIV to sleep permanently, providing a lasting and durable treatment against the v ...
Provincial Health Office OIC Dr. Fruserma Mary Uy during the training on responsible messaging about HIV to Bohol media practitioners on June 20, stressed the vital role of media in shaping public ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results